Key result
Acetazolamide, but not dichlorphenamide or bendroflumethiazide, prevented vacuolar myopathy and inhibited lactate efflux in K+-depleted rats.
Why the study?
Does acetazolamide prevent vacuolar myopathy in K+-depleted rats?
Does acetazolamide prevent vacuolar myopathy in K+-depleted rats?
Acetazolamide prevents vacuolar myopathy in K+-depleted rats, likely through inhibition of lactate transport rather than carbonic anhydrase inhibition.
This is the authors' abstract. We don't add key points for this paper.
Background and purpose: Acetazolamide and dichlorphenamide are carbonic anhydrase (CA) inhibitors effective in the clinical condition of hypokalemic periodic paralysis (hypoPP). Whether these drugs prevent vacuolar myopathy, which is a pathogenic factor in hypoPP, is unknown. The effects of these drugs on the efflux of lactate from skeletal muscle were also investigated.Experimental approach: For 10 days, K+‐depleted rats, a model of hypoPP, were administered 5.6 mg kg−1 day−1 of acetazolamide, dichlorphenamide or bendroflumethiazide (the last is not an inhibitor of CA). Histological analysis of vacuolar myopathy and in vitro lactate efflux measurements were performed in skeletal muscles from treated and untreated K+‐depleted rats, and also from normokalemic rats.Key results: About three times as many vacuoles were found in the type II fibres of tibialis anterioris muscle sections from K+‐depleted rats as were found in the same muscle from normokalemic rats. In ex vivo experiments, a higher efflux of lactate on in vitro incubation was found in muscles of K+‐depleted rats compared with that found in muscles from normokalemic rats. After treatment of K+‐depleted rats with acetazolamide, the numbers of vacuoles in tibialis anterioris muscle decreased to near normal values. Incubation with acetazolamide in vitro inhibited efflux of lactate from muscles of K+‐depleted rats. In contrast, bendroflumethiazide and dichlorphenamide failed to prevent vacuolar myopathy after treatment in vivo and failed to inhibit lactate efflux in vitro.Conclusions and implications: Acetazolamide prevents vacuolar myopathy in K+‐depleted rats. This effect was associated with inhibition of lactate transport, rather than inhibition of CA.
Answers are grounded in this paper and cite their sources.
Does not support acetazolamide for hypokalemic myopathy; hypothesis-generating for lactate transport inhibition in muscle.
No takes yet. Share an insight, caveat, or question.
Tricarico et al. (2008) studied Hypokalemic periodic paralysis (animal model). Acetazolamide, dichlorphenamide, or bendroflumethiazide vs. Untreated K+-depleted rats and normokalemic rats was evaluated on Histological analysis of vacuolar myopathy and in vitro lactate efflux. Acetazolamide, but not dichlorphenamide or bendroflumethiazide, prevented vacuolar myopathy and inhibited lactate efflux in K+-depleted rats.
Synapse has enriched 10 related papers. Consider them for comparative context: